| US 7,541,371 B2 | ||
| Method for treating a motor neuron disease | ||
| Yoshihiro Arakawa, Ibaraki-ken (Japan); and Makoto Miyazaki, Kanagawa-ken (Japan) | ||
| Assigned to Eisai R&D Management Co., Ltd., Tokyo-To (Japan) | ||
| Filed on Feb. 20, 2007, as Appl. No. 11/707,883. | ||
| Claims priority of provisional application 60/774544, filed on Feb. 21, 2006. | ||
| Claims priority of provisional application 60/874247, filed on Dec. 12, 2006. | ||
| Prior Publication US 2008/0027039 A1, Jan. 31, 2008 | ||
| Int. Cl. A61K 31/445 (2006.01) | ||
| U.S. Cl. 514—323 | 39 Claims |
| 1. A method for treating a motor neuron disease, comprising the step of administering a therapeutically effective amount of a compound having serotonin receptor antagonist activity or its pharmacologically acceptable salt or their solvate optionally together with a pharmaceutically acceptable carrier to a mammal for which the treatment of said disease is indicated. |